All patients (n = 90) | Anti-AQP4 Ab negative subgroup (n = 34) | Anti-AQP4 Ab positive subgroup (n = 56) | Test of significance | |
---|---|---|---|---|
WBC count | 6.85 (4.93–9.33) | 6.75(2.4–24) | 7.0(3.0-26.8) | p = 0.677 |
Neutrophil number | 4.2 (2.8-5) | 4.1(1-15.5) | 4.2(1.6–18) | p = 0.680 |
Lymphocyte number | 2.0 (1.2–3.5) | 1.85(0.4–10) | 2.1(0.48–6.3) | p = 0.848 |
HB level | 9.29 ± 1.76 | 9.52 ± 1.63 | 9.16 ± 1.84 | p = 0.347 |
Platelet count | 190 (117.5-280.25) | 189(10–540) | 190(63–701) | p = 0.479 |
MPV | 8.7 (7.15–10.83) | 8.45(5.4–14.5) | 8.75(5-12.6) | p = 0.878 |
Proteinuria % | 73.3 | 55.9 | 83.9 | p = 0.004* |
ESR first hour | 104.5 (86-125.25) | 65(20–120) | 75(35–145) | p = 0.142 |
CRP | 6 (3-18.25) | 5.5(1–56) | 7.5(1–96) | p = 0.184 |
C3 | 53(40.75-63) | 60(37.0-137) | 48.5(22–108) | p = 0.006* |
C4 | 12.5 (8–17) | 12.5(1.0–52.0) | 12.5(1.0–45.0) | p = 0.275 |
ANA % | 90 (100%) | 34(100) | 56(100) | P = 1.0 |
Anti dsDNA% | 70 (77.8%) | 27(79.4) | 43(76.8) | p = 0.771 |
LA % | 26 (28.9%) | 6(17.6) | 20(35.7) | p = 0.067 |
ACL % | 63 (70%) | 20(58.8) | 43(76.8) | p = 0.07 |
Patients who underwent echocardiography examination % | 57.8 | 41.2 | 67.9 | p = 0.013* |
Pericarditis % | 42.2 | 26.5 | 251.8 | p = 0.018* |
Valvular % | 22.2 | 17.6 | 25 | p = 0.416 |
Endocarditis % | 11.1 | 5.9 | 14.3 | p = 0.219 |
Myocarditis % | 8.9 | 5.9 | 10.7 | p = 0.435 |